Gene Expression Signature Predicts Immune-Related Adverse Events in Melanoma Patients
Gene expression signature predicts irAEs in melanoma patients treated with ipilimumab/nivolumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.